Epilepsy Monitoring Devices Market Size, Share, and Industry Analysis, By Product (Wearable Devices, Conventional Devices {Standard EEG, Video EEG, and Others}), By End-user (Hospitals & ASCs, Neurology Centers, Diagnostic Centers, and Others), and Regional Forecast till 2034

The epilepsy monitoring devices market size was valued at USD 619.1 million in 2025 and is expected to reach a market valuation of USD 651.8 million in 2026. Furthermore, the market is projected to reach a market valuation of USD 983.9 million by 2034, exhibiting a CAGR of 5.3% during the forecast period.

The global epilepsy monitoring devices market is experiencing significant growth, driven by increased utilization of video-EEG in EMUs, continuous EEG in ICUs, and ambulatory EEG at home, which is influencing key players to expand their product offerings.

• For instance, in April 2025, Cadwell Industries Inc. announced a strategic investment in Seer Medical, an Australian firm specializing in AI-driven home-based epilepsy diagnostics via its Seer Home video-EEG product.

Epilepsy Monitoring Devices Market Driver

Rising AI-enabled EEG Interpretation and Point-of-Care Adoption to Drive the Market Growth

In recent years, point-of-care EEG has expanded beyond neurology departments into emergency and critical care settings. Also, AI validation datasets and regulatory clearances are strengthening clinical confidence and accelerating procurement, particularly in neonatal and critical-care monitoring, where sensitivity and speed are essential. This is expected to drive the market growth in the upcoming years.

• For instance, in November 2025, Ceribell, Inc. received FDA 510(k) clearance for its next-gen Clarity algorithm for electrographic seizure detection in neonates.

Download Free sample to learn more about this report.

According to data published by the Epilepsy Alliance America, there were around 65 million people worldwide and 3.4 million people in the U.S. suffering from epilepsy in 2025.

Epilepsy Monitoring Devices Market Restraint

Shortage of Professionals to Restrict the Market Growth

Despite the higher demand for epilepsy monitoring devices, hospitals struggle to scale EEG monitoring due to shortages of trained staff and limited coverage, especially outside large epilepsy centers. As continuous EEG and EMU monitoring generate large data volumes, they require expert review. In such a scenario, the shortage of professionals is expected to slow down the adoption of epileptic monitoring devices, hindering market growth.

• For instance, in February 2022, the American Academy of Neurology (AAN) characterized the U.S. neurologist shortage as a “grave threat” to care delivery.

Epilepsy Monitoring Devices Market Opportunity

Increasing Home-based Monitoring Preference to Offer Lucrative Growth Opportunity

In recent years, families have been preferring home-based monitoring, as children often struggle with wired setups and electrode displacement. Moreover, regulatory expansions into younger age groups is also expected to broaden clinical use cases and accelerate hospital adoption of wearable EEG systems designed for real-world behavior.

• For instance, in March 2025, EPITEL announced expanded FDA clearance for the REMI wearable EEG for use in children as young as 1 year old.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence/Incidence of Epilepsy, by Key Countries/Region, 2025
• Technological Advancements in Epilepsy Monitoring Devices
• Key Industry Developments - (Partnerships, Mergers, and Acquisitions, etc.)

Analysis by Product

In terms of product, the market is segmented into wearable devices and conventional devices. The conventional devices are further sub-segmented into standard EEG, video EEG, and others.

The conventional segment is expected to hold the major share of the global market during the forecast period. EEG-based monitoring remains the clinical gold standard for confirming seizures, classifying seizure type, and localizing seizure onset. As a result, key players are expanding conventional devices, which is anticipated to drive the segment’s growth.

• For instance, in May 2025, Natus launched BrainWatch, a point-of-care EEG solution for critical-care environments that integrates with the trusted NeuroWorks platform to address customer needs for rapid, reliable EEG monitoring in health systems and small hospitals worldwide.

Analysis by End-user

Based on end-user, the market is divided into hospitals & ASCs, neurology centers, diagnostic centers, and others.

The hospital & ASCs segment is expected to hold the largest share of the global market during the forecast period. Epilepsy diagnosis and seizure classification require EEG-based monitoring, especially video EEG and continuous EEG, which are primarily conducted in hospital settings. As a result, these settings account for high-value EEG system installations and monitoring volumes, which are anticipated to drive the segment’s growth during the forecast period.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the 41.6% share of the global epilepsy monitoring devices market in 2025. The region's growth is attributed to higher EMU density, ICU EEG utilization, faster commercialization pathways, and earlier adoption of AI-assisted/point-of-care EEG, which is attracting key players to expand product availability in the region.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. The region’s growth is attributed to expanding neuro-care infrastructure, rising diagnosis rates, and higher investments in tertiary hospitals, which are accelerating the adoption of epilepsy monitoring devices due to the growing prevalence of epilepsy in countries such as China and India.

• For instance, according to the data provided by the Institute of Neurosciences Kolkata in January 2026, the prevalence of epilepsy is 5.59 per 1000 population in India.

Key Players Covered

The global epilepsy monitoring devices market is highly competitive, with several companies focusing on new product development and geographic expansion to expand their market reach.

The report includes the profiles of the following key players:

• Cadwell Industries Inc (U.S.)
• Compumedics Limited (Australia)
• Nihon Kohden Corporation (Japan)
• Natus (U.S.)
• Ceribell, Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• EPITEL (U.S.)
• Zeto Inc. (U.S.)
• EMFIT (Finland)
• Empatica Inc. (U.S.)

Key Industry Developments

• December 2025: Nihon Kohden Corporation showcased its advanced EEG portfolio at the American Epilepsy Society (AES) 2025 to advance neurological care.
• June 2024: Zeto Inc. received FDA 510(k) clearance for its next-generation ONE EEG brain monitoring product, featuring a user-friendly headset with 21 soft-tip electrodes.